… efficacy with higher doses, 12 ,15 clinicians should remain cognizant of the disadvantages of
higher-activity RAI, including patient … -activity RAI to evaluate their efficacy concerning rates …

… efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with
differentiated thyroid cancer … remnant ablation in patients with differentiated thyroid cancer. …

… Overall, 4000 patients with papillary thyroid cancer, differentiated thyroid … mCi) in order to
maximize therapeutic activity and radioiodine effectiveness in metastatic differentiated thyroid …

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy
in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate …

… RAI remnant ablation consists of the destruction of the remnant thyroid tissue with the …
adverse effects of radioiodine therapy for differentiated thyroid carcinoma—a systematic review. …

… efficacy of 131 I remnant ablation.” However, in their 2019 provocative editorial entitled “Guidelines
are not gospels,” Daniels and Kopp, 6 as they looked toward the future, stated, “We …

… However, the efficacy of these … RAI remnant ablation was performed in indicated patients
4–6 weeks after the initial operation. At our institution, high-dose (>100 mCi) remnant ablation is …

… ” [8], which compared the efficacy of two lower RAI activities: … 131I ablation in patients with
differentiated thyroid carcinoma: … , RAI activity of 30 mCi demonstrates comparable efficacy as …

… 5 year efficacy of thyroid remnant radioiodine ablation using … with 726 patients with low-risk
differentiated thyroid cancer who … on RAI remnant ablation or RAI treatment are needed [26]. …

… We speculated that radioiodine remnant ablation (RRA) could be performed less frequently
in differentiated thyroid cancer (DTC) patients, if the recommendations of the 2018 Italian …